GlassScriptPhysician profile
Harold L Dalton
NPI 1710988332
$2,676.32
in general payments reported to CMS, 2019-2025
23 companies · $91.97 in 2025
The $91.97 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,137 · 2020: $101 · 2021: $305 · 2022: $398 · 2023: $485 · 2024: $159 · 2025: $91.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $827.06 | 2019 | |
| Boston Scientific Corporation | $497.01 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Stryker Corporation | $320.86 | 2019-2022 | |
| Medtronic, INC. | $232.77 | 2023 | Intellis Adaptivestim |
| Amgen INC. | $118.14 | 2019-2022 | |
| Medtronic USA, INC. | $86.22 | 2019-2020 | |
| Protega Pharmaceutials INC | $80.30 | 2022 | |
| Electronic Waveform Lab, INC. | $76.69 | 2021 | |
| Grt US Holding, INC. | $74.17 | 2021-2022 | |
| Almatica Pharma LLC | $60.54 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $32.23 | 2020-2023 | Xtampza |
| Depuy Synthes Sales INC. | $31.97 | 2022 | |
| Redhill Biopharma INC. | $30.05 | 2021 | |
| Spinal Simplicity, LLC | $30.00 | 2023 | Ha Minuteman G3-R |
| Camber Spine Technologies LLC | $29.31 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $28.58 | 2019 | |
| Merit Medical Systems INC | $28.27 | 2020-2021 | |
| Curonix LLC | $16.98 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $16.59 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.73 | 2023 | Relistor |
| Sanara Medtech INC. | $14.94 | 2023 | Celleraterx |
| Astrazeneca Pharmaceuticals LP | $14.03 | 2019 | |
| Alvogen INC | $13.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Dalton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.